At CTAD 2012 we will once again bring the key leaders involved in clinical trials to appreciate the full spectrum of AD from an asymptomatic stage through dementia, discuss the development of the next generation of Alzheimer’s disease treatments as well as learn to harmonize the various neuroimaging techniques and their analyses.